{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:30:28Z","timestamp":1780457428984,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12014\/1"],"award-info":[{"award-number":["MC_UU_12014\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["C0365"],"award-info":[{"award-number":["C0365"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1053\/j.gastro.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T22:24:42Z","timestamp":1557440682000},"page":"692-704.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir"],"prefix":"10.1053","volume":"157","author":[{"given":"Peter A.C.","family":"Wing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-2971","authenticated-orcid":false,"given":"Meleri","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-618X","authenticated-orcid":false,"given":"Michelle","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-015X","authenticated-orcid":false,"given":"Sampath","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-1983","authenticated-orcid":false,"given":"Connor","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Yiu","family":"Jason Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2637-2307","authenticated-orcid":false,"given":"Elihu","family":"Aranday-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Da Silva Filipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McLauchlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-7137","authenticated-orcid":false,"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morven","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2790-8353","authenticated-orcid":false,"given":"Azim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2019.05.007_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1586\/14787210.2013.855126","article-title":"Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection","volume":"11","author":"Rodriguez-Torres","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1053\/j.gastro.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/apt.13883","article-title":"Simeprevir in combination with sofosbuvir in treatment-naive and -experienced patients with hepatitis C virus genotype 4 infection: a phase III, open-label, single-arm study\u00a0(PLUTO)","volume":"45","author":"Buti","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.27375","article-title":"Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir","volume":"61","author":"Donaldson","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29256","article-title":"Sofosbuvir-velpatasvir with ribavirin for 24 weeks in HCV patients previously treated with a direct-acting antiviral regimen","author":"Gane","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2017.03.047","article-title":"Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic hcv infection: 2 phase 3 randomized trials","volume":"153","author":"Jacobson","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.05.007_bib8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1056\/NEJMoa1512612","article-title":"Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection","volume":"373","author":"Foster","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1542-3565(05)00527-6","article-title":"Prevalence of hepatitis C-related cirrhosis in elderly Asian patients infected in childhood","volume":"3","author":"D'Souza","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MEG.0b013e3283488aba","article-title":"Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse","volume":"23","author":"Shoeb","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3851\/IMP3149","article-title":"In\u00a0vitro selection of resistance to sofosbuvir in HCV replicons of genotype 1 to 6","volume":"22","author":"Xu","year":"2017","journal-title":"Antivir Ther"},{"key":"10.1053\/j.gastro.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.30225","article-title":"Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r","volume":"69","author":"Fourati","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jhep.2017.01.007","article-title":"NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome","volume":"66","author":"Zeuzem","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2019.05.007_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2016.06.019","article-title":"Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis","volume":"65","author":"Cheung","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2019.05.007_bib19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.27570","article-title":"Development and validation of a \"capture-fusion\" model to study drug sensitivity of patient-derived hepatitis C","volume":"61","author":"Cunningham","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib20","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.27934","article-title":"Hepatitis C virus drug resistance-associated substitutions: state\u00a0of the art summary","volume":"62","author":"Lontok","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12859-018-2459-9","article-title":"GLUE: a flexible software system for virus sequence data","volume":"19","author":"Singer","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1053\/j.gastro.2019.05.007_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1053\/j.gastro.2015.07.043","article-title":"Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis c virus genotype 2 infection","volume":"149","author":"Foster","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.05.007_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"10.1053\/j.gastro.2019.05.007_bib24","first-page":"365","article-title":"Hepatitis C Virus RNA-dependent RNA polymerase (NS5B Polymerase)","volume":"19","author":"Hagedorn","year":"1999","journal-title":"Methods Mol Med"},{"issue":"9","key":"10.1053\/j.gastro.2019.05.007_bib25","article-title":"Development of global consensus sequence and analysis of highly conserved domains of the HCV NS5B protein","volume":"12","author":"Waheed","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1053\/j.gastro.2019.05.007_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/jhep.2001.22765","article-title":"Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase","volume":"33","author":"Qin","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib27","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1074\/jbc.M111392200","article-title":"Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity","volume":"277","author":"Shirota","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.gastro.2019.05.007_bib28","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/JVI.78.6.2738-2748.2004","article-title":"Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon","volume":"78","author":"Shimakami","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2019.05.007_bib29","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00018-014-1695-z","article-title":"Common and unique features of viral RNA-dependent polymerases","volume":"71","author":"te Velthuis","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.gastro.2019.05.007_bib30","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/AAC.01256-12","article-title":"Efficient replication of genotype 3a and 4a hepatitis c virus replicons in human hepatoma cells","volume":"56","author":"Saeed","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.gastro.2019.05.007_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/j.gastro.2016.07.013","article-title":"Robust\u00a0HCV genotype 3a infectious cell culture system\u00a0permits identification of escape variants with resistance to sofosbuvir","volume":"151","author":"Ramirez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.05.007_bib32","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1128\/JVI.01860-14","article-title":"Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus","volume":"88","author":"Sheldon","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2019.05.007_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-pibrentasvir for 8 or 12 weeks in hcv genotype 1 or 3 infection","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jiv564","article-title":"L159F\u00a0and V321A sofosbuvir-associated hepatitis C virus NS5B substitutions","volume":"213","author":"Svarovskaia","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2019.05.007_bib35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.05.007_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.gastro.2016.06.002","article-title":"Prevalence of resistance-associated substitutions in HCV NS5A, NS5B, or NS3 and outcomes of treatment with ledipasvir and sofosbuvir","volume":"151","author":"Sarrazin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2019.05.007_bib39","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.27570","article-title":"Development and validation of a \"capture-fusion\" model to study drug sensitivity of patient-derived hepatitis C","volume":"61","author":"Cunningham","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.05.007_bib40","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1128\/JVI.01860-14","article-title":"Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus","volume":"88","author":"Sheldon","year":"2014","journal-title":"J\u00a0Virol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519408652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519408652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:45:50Z","timestamp":1762163150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519408652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0016508519408652"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2019.05.007","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}